Home » Topics » Briefs » Other news to note

Other news to note
RSS

Perrigo completes divestiture of API business

Nov. 23, 2017

EMA launches improved version of EudraVigilance system for safety monitoring

Nov. 22, 2017

EMA announces relocation to the Netherlands

Nov. 21, 2017

OphthaliX completes merger with Wize Pharma

Nov. 21, 2017

Deerfield Management and Johns Hopkins announce creation of Bluefield Innovations

Nov. 17, 2017

Zymeworks and Janssen Biotech enter license agreement to develop bispecific antibody therapeutics

Nov. 16, 2017

Inozyme Pharma announces series A financing to develop its lead enzyme replacement therapy

Nov. 16, 2017

AstraZeneca presents regulatory and pipeline developments of third quarter 2017

Nov. 16, 2017

Otsuka offers overview of third quarter 2017

Nov. 15, 2017

Homology Medicines enters R&D collaboration with Novartis

Nov. 14, 2017

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...